- Home
- HURA vs DMA Comparison
HURA vs DMA Comparison
Compare HURA & DMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | HURA | DMA |
|---|---|---|
| Founded | 2009 | N/A |
| Country | United States | United States |
| Employees | 19 | N/A |
| Industry | | Trusts Except Educational Religious and Charitable |
| Sector | | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 87.5M | 76.4M |
| IPO Year | N/A | 2011 |
Fundamental Metrics
Financial Performance| Metric | HURA | DMA |
|---|---|---|
| Price | $2.12 | $8.29 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $10.00 | N/A |
| AVG Volume (30 Days) | ★ 899.6K | 39.9K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.41 | $7.17 |
| 52 Week High | $4.41 | $9.15 |
Technical Indicators
Market Signals| Indicator | HURA | DMA |
|---|---|---|
| Relative Strength Index (RSI) | 72.36 | 39.34 |
| Support Level | $1.56 | $7.95 |
| Resistance Level | $2.16 | $8.95 |
| Average True Range (ATR) | 0.22 | 0.24 |
| MACD | 0.03 | 0.00 |
| Stochastic Oscillator | 85.25 | 40.82 |
Price Performance
Historical ComparisonAbout HURA TuHURA Biosciences Inc.
TuHURA Biosciences Inc is a Phase 3 registration stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. The company's personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. It is preparing to initiate a single randomized placebo-controlled Phase 3 registration trial of IFx-2.0 administered as an adjunctive therapy to Keytruda (pembrolizumab) in first-line treatment for advanced or metastatic Merkel Cell Carcinoma.
About DMA Destra Multi-Alternative Fund
Destra Multi-Alternative Fund is a non-diversified, closed-end management investment company that operates as an interval fund with a continuous offering of fund shares. The investment objective of the fund is to seek returns from capital appreciation and income with an emphasis on income generation.